Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 442 record(s)

Req # A-2020-001670

Adverse Reaction Report (AERs) for Naltrexone. Report number: 000921857 (ADRs) for Hydromorphone. Report numbers: 914621, 918738. (ADR) for Heparin. Report number: E2B_02830812.

Organization: Health Canada

26 page(s)
April 2021

Req # A-2020-001677

Adverse Drug Reaction (ADR) for METRONIDAZOLE. Report number: E2B_01198405.

Organization: Health Canada

64 page(s)
April 2021

Req # A-2020-001689

Adverse Reaction Reports (AERs) for Diclectin (doxylamine succinate / pyridoxine hydrochloride). Report numbers: 000925695, 000925698, 000925727, 000925952, E2B_03296221.

Organization: Health Canada

30 page(s)
April 2021

Req # A-2020-001763

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_03473172.

Organization: Health Canada

15 page(s)
April 2021

Req # A-2020-001896

Adverse Reaction Reports (AERs) for Mifegymiso. Report numbers: 000924450, 000931171. (ADR) for Misoprostol. Report number: 000931875.

Organization: Health Canada

24 page(s)
April 2021

Req # A-2021-000006

Adverse Reaction Reports (AERs) for Keytruda. Report numbers: 000700874, 000701307, 000702256, 000702349, 000705041, 000705329, 000705536, 000705565, 000706160.

Organization: Health Canada

43 page(s)
April 2021

Req # A-2021-000013

Adverse Drug Reaction (ADR) for Botulinum toxin indication/injection site. Report number: E2B_00476395.

Organization: Health Canada

15 page(s)
April 2021

Req # A-2021-000020

Adverse Drug Reaction (ADR). Report number: 000929307.

Organization: Health Canada

6 page(s)
April 2021

Req # A-2021-000031

Adverse Reaction Reports (AERs). Report numbers: 000925559, 000926151, 000924858.

Organization: Health Canada

12 page(s)
April 2021

Req # A-2019-00148

All documents related to the renewal of the lease for NCC land at 20 Laurier Street in Gatineau, site of the Kruger Products plant, for the period from January 1, 2018 to August 27, 2019.

Organization: National Capital Commission

2096 page(s)
April 2021
Date modified: